Ferric Contrast inc is developing a novel family of iron-based MRI contrast agents. The company is aimed at making MRI imaging safer and is working on compounds to identify liver tumors and kidney tumors. The firm's contrast agents can be used to produce high-quality magnetic resonance images of the brain, vasculature, liver and kidneys, as well as for a variety of tumors resulting from cancer.